Select Medical Holdings Corporation

Select Medical Holdings Corporation

SEMNYSE / NASDAQHealthcareMid cap

$16.51-$0.02 (-0.1%)

Last close · Data as of Jun 30, 2026

Market cap
$2.0B
P/E
14.0x
EV / EBITDA
9.2x
Revenue
$5.5B
Net margin
2.7%
ROCE
6.9%

Hidden because the last close is more than three trading days older than the latest prices of its class.

Select Medical Holdings Corporation price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 30 Jun 2026 close.

1M
Stale
3M
Stale
6M
Stale
1Y
Stale
5Y
Stale
  • Hidden because the last close is more than three trading days older than the latest prices of its class.

52-week range

Day change -$0.02 (-0.1%) from $16.53 to $16.51 · Last close Jun 30, 2026

Best weekday to invest, historically

The same weekly amount in SEM, bought on each weekday since 2021.

News & filings

What Select Medical Holdings filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

ConcernReturn on equity of 8.6% against a peer median of 3.2%.

Strengths (1)

  • Free cash flow was 0.80 times net profit in fiscal 2025.
  • Prices are as of 30 Jun 2026; price-based points are paused until newer prices arrive.

Prices to the 30 Jun 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States.

Read moreShow less

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. The Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. The Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, pelvic health rehabilitation, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.

Sector
Healthcare
Shares outstanding
126.1M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$2.0B
P/E
14.0x
P/B
1.2x
EV / EBITDA
9.2x
EV / Sales
0.9x
P/S
0.4x
52-week high
$16.66
52-week low
$11.77

Profitability

Operating margin
6.2%
Net margin
2.7%
EBITDA margin
9.7%
ROE
8.6%
ROCE
6.9%
ROA
2.5%
Asset turnover
0.93

Growth

Revenue
$5.5B
Revenue growth, 1Y
5.1%
Revenue CAGR, 3Y
5.8%
Net profit growth, 1Y
-31.7%
Free cash flow
$117.2M

Solvency

Current ratio
1.04
Debt / Equity
1.68
Debt / Assets
0.49
CFO / Net profit
2.37
Cash / Market cap
1.3%

Where the revenue went

Of every $100 of FY2025 revenue, $3 was left as net income.

Select Medical Holdings Corporation income statement flow, FY2025
Select Medical Holdings Corporation income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$4.8B
RevenueGross profit$629.3M
Gross profitSelling, general and administrative$154.4M
Gross profitOther operating expenses$138.7M
Gross profitOperating income$336.2M
Operating incomePretax income$272.8M
Operating incomeInterest and other expense$63.4M
Pretax incomeTax and other$126.5M
Pretax incomeNet income$146.2M

Revenue and net profit

Revenue grew 5.1% in FY2025; net profit is the dashed line.

Select Medical Holdings Corporation revenue and net profit by fiscal year
Select Medical Holdings Corporation revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$4.6B$159.0M
FY2023$4.8B$243.5M
FY2024$5.2B$214.0M
FY2025$5.5B$146.2M

Cash flows

FY2025: $346.5M from operations, $117.2M free after investment (dashed).

Select Medical Holdings Corporation operating and free cash flow by fiscal year
Select Medical Holdings Corporation operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$284.8M$94.5M
FY2023$582.1M$352.9M
FY2024$517.9M$295.7M
FY2025$346.5M$117.2M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$5.5B+5.1%1Y
EBITDA
$531.0M+4.7%1Y
Net profit
$146.2M-31.7%1Y
Cash from operations
$346.5M-33.1%1Y
Free cash flow
$117.2M-60.3%1Y
Revenue CAGR, 3Y
5.8%
Net profit CAGR, 3Y
-2.8%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$5.5B$531.0M$146.2M$117.2M8.6%+5.1%-31.7%

Monthly returns

Month-by-month returns of SEM across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$5.9B
Liabilities$3.8B
Equity$2.0B
Paid-in capital$874.9M
Retained earnings$837.0M
Minority interest$330.2M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; SEM highlighted.

P/E against peers

SEM trades at 14.0x earnings against a peer median of 4.7x (a 195% premium).

  1. Select Medical Holdings Corporation (this company)14.0x

Not shown (no positive earnings and no EV / Sales): Supernus Pharmaceuticals, Inc., Acadia Healthcare Company, Inc., Neogen Corporation, Sarepta Therapeutics, Inc.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
Select Medical Holdings CorporationSEMthis companyP/E ↑ premium$2.0B14.0x1.2x8.6%9.2x
Supernus Pharmaceuticals, Inc.SUPN$2.6B-67.3x2.4x-3.6%58.9x
TransMedics Group, Inc.TMDX$2.5B13.0x5.2x40.2%16.8x
Acadia Healthcare Company, Inc.ACHC$2.3B-2.1x1.2x-56.6%-6.5x
Prestige Consumer Healthcare Inc.PBH$2.2B11.3x1.1x10.1%9.5x
LeMaitre Vascular, Inc.LMAT$2.1B37.0x5.4x14.7%25.3x
Neogen CorporationNEOG$2.0B-1.8x1.0x-52.7%-2.9x
ADMA Biologics, Inc.ADMA$1.8B12.6x3.9x30.8%9.3x
Sarepta Therapeutics, Inc.SRPT$1.8B-2.5x1.5x-62.5%-3.2x
Peer median—4.7x2.0x3.2%9.4x

Year-to-date ROI

SEM since 1 January, against earlier years.

Historical volatility

SEM's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

Select Medical Holdings Corporation operating margin by fiscal year
Select Medical Holdings Corporation operating margin by fiscal year
DateOperating margin
FY20223.1%
FY20235.5%
FY20245.2%
FY20256.2%
LineFY2025
Cost of revenueCost Of Revenue$4.8B
Gross profitGross Profit$629.3M
Operating expensesOperating Expense$293.1M
Other operating expensesOther Operating Expenses-$1.6M
Depreciation and amortisationDepreciation And Amortization In Income Statement$140.3M
Depreciation, amortisation and depletionDepreciation Amortization Depletion Income Statement$140.3M
Total expensesTotal Expenses$5.1B
Pretax incomePretax Income$272.8M

Learn while you research

Academy chapters picked for Select Medical Holdings Corporation and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Leverage RatiosDebt/Equity of 1.68 is elevated, understand what that means for solvency.6 min read
  3. 03 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  4. 04 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  5. 05 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →